Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Technology in Cancer Research & Treatment|June 12, 2025
Central-boost Ablative Radiation Therapy for Solid Tumors: Study Protocol of a Single-arm, Phase II Trial (CBART)Lingong Jiang, Yangsen Cao, Xiaolan Yin, et al.
Technology in Cancer Research & Treatment|September 26, 2023
A Predictive Model to Evaluate Pathologic Complete Response in Rectal AdenocarcinomaShuiwang Qing, Lei Gu, Tingting Du, et al.
Nanoscale|August 8, 2020
"Layer peeling" co-delivery system for enhanced RNA interference-based tumor associated macrophages-specific chemoimmunotherapyTianqi Wang, Weiwei Mu, Feifei Li, et al.
Future Oncology (London, England)|June 30, 2025
ADJUPANC protocol: a phase III study of adjuvant chemotherapy versus chemoradiotherapy for pancreatic cancerXiaofei Zhu, Wenyu Liu, Lingong Jiang, et al.
Nanomedicine (London, England)|June 11, 2019
Preparation and evaluation of etoposide-loaded lipid-based nanosuspensions for high-dose treatment of lymphomaXiaolan Yin, Leiqiang Han, Shengjun Mu, et al.
Cancers|January 21, 2023
Multiomics Analysis Reveals Cuproptosis-Related Signature for Evaluating Prognosis and Immunotherapy Efficacy in Colorectal CancerRong He, Heping Zhang, Huaxin Zhao, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|June 27, 2022
Treatment of the Gastroesophageal Reflux Disease with Chinese Herbal Medicine (BanxiaXiexin Decoction): Evidence from Meta-AnalysisJiali Liu, Jinke Huang, Beihua Zhang, et al.
Experimental and Therapeutic Medicine|April 8, 2020
Overexpression of microRNA-96 is associated with poor prognosis and promotes proliferation, migration and invasion in cholangiocarcinoma cells via <i>MTSS1</i>Xiaolan Yin, Zongtao Chai, Xiaoting Sun, et al.
Frontiers in Cell and Developmental Biology|March 6, 2026
Patient-derived organoids (PDOs): a novel preclinical platform to overcome challenges in cancer immunotherapyDongmei Ni, Junjie Xing, Gengming Niu, et al.
Nanomedicine (London, England)|June 28, 2018
Unified D-α-Tocopherol 5-Fu/SAHA bioconjugates self-assemble as complex nanodrug for optimized combination therapyLeiqiang Han, Tianqi Wang, Shengjun Mu, et al.
Pageof 5